Skip to main content

Your search for “Inflammatory Bowel Disease” returned 55 results

Novel Cytokine Protects Mice from Colitis

August 24, 2011

Inflammatory bowel disease (IBD), which affects more than 1 million patients in North America, results from an uncontrolled immune response triggered by environmental factors, such as bacteria, in people genetically predisposed to the disorder. Ulcerative colitis, or inflammation of the lining of the colon, is one such condition.

Microrobot-packed Pill Shows Promise for Treating Inflammatory Bowel Disease in Mice

June 26, 2024

Engineers have developed a pill that releases microscopic robots, or microrobots, into the colon to treat inflammatory bowel disease (IBD). The experimental treatment, given orally, has shown success in mice. It significantly reduced IBD symptoms and promoted the healing of damaged colon tissue without causing toxic side effects.

Hard to Study Mutations Implicated in the Expression of Genes Associated with Schizophrenia and More

November 5, 2019

Hard-to-study mutations in the human genome, called short tandem repeats, known as STRs or microsatellites, are implicated in the expression of genes associated with complex traits including schizophrenia, inflammatory bowel disease and even height and intelligence.

Study Shows Ozanimod as Effective in Treating Ulcerative Colitis

May 4, 2016

Researchers at University of California San Diego School of Medicine have shown that ozanimod (RPC1063), a novel drug molecule, is moderately effective in the treatment of ulcerative colitis. Results of the Phase II clinical trial will appear in the May 5 issue of the New England Journal of Medicine.

American Gut Project Crowdfunds $1 Million to Study the Human Microbiome

October 29, 2015

…associated with things like inflammatory bowel disease, cancer, even autism. To participate, go to What can we learn from the human microbiome? So far, the American Gut Project team is finding that, in general, a healthy gut microbiome is one with a diverse number of bacterial species in it.…

Crohn’s Disease Research Bolstered With Grant from Helmsley Charitable Trust

August 23, 2023

A grant of nearly $3.5 million from The Leona M. and Harry B. Helmsley Charitable Trust is supporting research at UC San Diego to identify better, more targeted treatments for people living with Crohn’s disease.

Two Studies Identify Potential New Drug for Crohn’s Disease and Ulcerative Colitis

August 21, 2013

…medication, has shown positive results for treating both Crohn’s disease and ulcerative colitis, according to researchers at the University of California San Diego, School of Medicine. The findings, published in two papers, will appear in the August 22 issue of the New England Journal of Medicine (NEJM).

U.S. News & World Report: UC San Diego #1 for Gastroenterology and Hepatology Research

October 28, 2020

U.S. News & World Report named University of California San Diego School of Medicine a top global university and ranked the divisions of Gastroenterology and Hepatology #1 in the world for research.

Dog Poop Microbiome Predicts Canine Inflammatory Bowel Disease

October 3, 2016

…use dogs as animal models for humans with this disease. The study is published October 3 in Nature Microbiology.

New Partnership Explores Future Treatments Using Breast Milk and Microbiome

April 29, 2019

Two renowned research centers at University of California San Diego are joining forces to take a deeper look at how components of human milk and the microbiome can change the course of therapeutics for infant and adult diseases.

Category navigation with Social links